Temat: "Bone Density" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Effects of denosumab on rheumatic diseases and refractory glucocorticoid-induced osteoporosis: a prospective study.
Autorzy :: Ishida T; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Yoshida S; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Fujiki Y; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Hata K; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Kotani T; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
Takeuchi T; Department of Internal Medicine (IV), Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan. .; Pokaż więcej
Źródło :: Archives of osteoporosis [Arch Osteoporos] 2021 Feb 23; Vol. 16 (1), pp. 39. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*/adverse effects
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Rheumatic Diseases*/drug therapy
Bone Density ; Denosumab/adverse effects ; Glucocorticoids/adverse effects ; Humans ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: [Progress of change in bone mineral density after knee arthroplasty].
Autorzy :: Wei W; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Wu Y; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Zeng Y; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.
Shen B; Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China.; Pokaż więcej
Źródło :: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery [Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi] 2021 Jan 15; Vol. 35 (1), pp. 124-129.
Typ publikacji :: Journal Article
MeSH Terms :: Arthroplasty, Replacement, Knee*/adverse effects
Bone Density Conservation Agents*/therapeutic use
Bone Resorption*/etiology
Bone Resorption*/prevention & control
Bone Density ; Humans ; Tibia/surgery
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: The Basics of Bone Physiology, Healing, and Osteoporosis.
Autorzy :: Dimar JR
Lane JM
Lehman RA Jr
Anderson PA; Pokaż więcej
Źródło :: Instructional course lectures [Instr Course Lect] 2021; Vol. 70, pp. 527-536.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Osteoporotic Fractures*
Bone Density ; Diphosphonates ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
Autorzy :: Binkley N; University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. .
Orwoll E; Oregon Health & Science University, Portland, OR, USA.
Chapurlat R; INSERM UMR 1033, Université de Lyon, Hôpital Édouard Herriot, Lyon, France.
Langdahl BL; Aarhus University Hospital, Aarhus, Denmark.
Scott BB; Merck & Co., Inc., Kenilworth, NJ, USA.
Giezek H; MSD Europe Inc., Brussels, Belgium.
Santora AC; Merck & Co., Inc., Kenilworth, NJ, USA.; Pokaż więcej
Źródło :: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Jan; Vol. 32 (1), pp. 173-184. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Biphenyl Compounds*/adverse effects
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Aged ; Bone Density ; Double-Blind Method ; Humans ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Rationale for Bone Health Optimization in Patients Undergoing Orthopaedic Surgery.
Autorzy :: Anderson PA
Dimar JR
Lane JM
Lehman RA Jr; Pokaż więcej
Źródło :: Instructional course lectures [Instr Course Lect] 2021; Vol. 70, pp. 355-366.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Fractures, Bone*/surgery
Orthopedic Procedures*/adverse effects
Orthopedics*
Osteoporosis*
Bone Density ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.
Autorzy :: Watts NB; Mercy Health Osteoporosis and Bone Health Services, Cincinnati, OH, USA.
Dore RK; Robin K. Dore, MD, Inc., Tustin, CA, USA.
Baim S; Rush University Medical Center, Chicago, IL, USA.
Mitlak B; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA. .
Hattersley G; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA.
Wang Y; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA.
Rozental TD; Beth Israel Deaconess Medical Center, Boston, MA, USA.
LeBoff MS; Brigham and Women's Hospital, Boston, MA, USA.; Pokaż więcej
Źródło :: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Jan; Vol. 32 (1), pp. 55-61. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :: Clinical Trial, Phase III; Journal Article
MeSH Terms :: Alendronate*/therapeutic use
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/epidemiology
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/etiology
Osteoporotic Fractures*/prevention & control
Aged ; Bone Density ; Double-Blind Method ; Female ; Forearm ; Humans ; Incidence ; Middle Aged ; Postmenopause
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Comprehensive evaluation of bone health using DXA and pQCT in an Indian boy with osteogenesis imperfecta.
Autorzy :: Karguppikar MB; Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India.
Ekbote V; Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India.
Khadilkar A; Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India .; Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, Maharashtra, India.
Khadilkar V; Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India.; Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, Maharashtra, India.; Pokaż więcej
Źródło :: BMJ case reports [BMJ Case Rep] 2020 Dec 13; Vol. 13 (12). Date of Electronic Publication: 2020 Dec 13.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Absorptiometry, Photon*
Bone Density*
Tomography, X-Ray Computed*/methods
Osteogenesis Imperfecta/*diagnostic imaging
Osteogenesis Imperfecta/*physiopathology
Bone Density Conservation Agents/therapeutic use ; Calcium/therapeutic use ; Child ; Diphosphonates/therapeutic use ; Fractures, Bone/etiology ; Fractures, Bone/prevention & control ; Humans ; Male ; Osteogenesis Imperfecta/drug therapy ; Vitamin D/therapeutic use ; Zoledronic Acid/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study.
Autorzy :: Zheng WB; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Dai Y; Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Hu J; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Zhao DC; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Wang O; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Jiang Y; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Xia WB; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Xing XP; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the.
Li M; From the (1)Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, and the. Electronic address: .; Pokaż więcej
Źródło :: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2020 Dec; Vol. 26 (12), pp. 1477-1485.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Muscular Dystrophy, Duchenne*/complications
Muscular Dystrophy, Duchenne*/drug therapy
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*
Alendronate ; Bone Density ; Child ; Diphosphonates/therapeutic use ; Female ; Humans ; Imidazoles/therapeutic use ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Treatment of high fracture risk patients in routine clinical practice.
Autorzy :: Lesnyak O; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia. .; Saint-Petersburg Municipal Clinical Rheumatology Hospital No. 25, St. Petersburg, Russia. .
Gladkova E; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia.; Saint-Petersburg Municipal Clinical Rheumatology Hospital No. 25, St. Petersburg, Russia.
Aleksandrov N; Lilly Pharma LLC, Moscow, Russia.
Belaya Z; National Medical Research Center of Endocrinology, Moscow, Russia.
Belova K; Yaroslavl State Medical University, Yaroslavl, Russia.
Bezlyudnaya N; Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement, Cheboksary, Russia.
Dobrovolskaya O; Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia.
Dreval A; Moscow Regional Research and Clinical Institute named after M.F. Vladimirsky, Moscow, Russia.
Ershova O; Yaroslavl State Medical University, Yaroslavl, Russia.
Grebennikova T; National Medical Research Center of Endocrinology, Moscow, Russia.
Kryukova I; Moscow Regional Research and Clinical Institute named after M.F. Vladimirsky, Moscow, Russia.
Mazurenko S; St Petersburg State University, St. Petersburg, Russia.
Priymak D; Lilly Pharma LLC, Moscow, Russia.
Rozhinskaya L; National Medical Research Center of Endocrinology, Moscow, Russia.
Samigullina R; North West State Medical University named after I.I.Mechnikov, St. Petersburg, Russia.
Solodovnikov A; Ural State Medical University, Yekaterinburg, Russia.
Toroptsova N; Research Institute of Rheumatology named after V.A. Nasonova, Moscow, Russia.; Pokaż więcej
Źródło :: Archives of osteoporosis [Arch Osteoporos] 2020 Nov 20; Vol. 15 (1), pp. 184. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*
Osteoporotic Fractures*/drug therapy
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/prevention & control
Spinal Fractures*/epidemiology
Spinal Fractures*/prevention & control
Adult ; Aged ; Aged, 80 and over ; Bone Density ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Teriparatide/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Autorzy :: McClung MR; Oregon Osteoporosis Center, 2881 NW Cumberland Road, Portland, OR 97210, USA. .; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia. .
Bolognese MA; Bethesda Health Research Center, Bethesda, MD, USA.
Brown JP; Laval University and CHU de Québec (CHUL) Research Centre, Québec City, QC, Canada.
Reginster JY; University of Liège, Liège, Belgium.; King Saud University, Riyadh, Kingdom of Saudi Arabia.
Langdahl BL; Aarhus University Hospital, Aarhus, Denmark.
Maddox J; Amgen Inc., Thousand Oaks, CA, USA.
Shi Y; Amgen Inc., Thousand Oaks, CA, USA.
Rojeski M; Amgen Inc., Thousand Oaks, CA, USA.
Meisner PD; UCB Pharma, Brussels, Belgium.
Grauer A; Amgen Inc., Thousand Oaks, CA, USA.; Pokaż więcej
Źródło :: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2020 Nov; Vol. 31 (11), pp. 2231-2241. Date of Electronic Publication: 2020 Jul 04.
Typ publikacji :: Clinical Trial, Phase II; Journal Article
MeSH Terms :: Antibodies, Monoclonal*/administration & dosage
Bone Density Conservation Agents*/administration & dosage
Osteoporosis, Postmenopausal*/drug therapy
Zoledronic Acid*/administration & dosage
Aged ; Bone Density ; Female ; Humans ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Letter to the Editor: "Delayed Denosumab Injections and Bone Mineral Density Response: En Electronic Health Record-Based Study".
Autorzy :: Mazziotti G; Endocrinology, Diabetology and Andrology Unit, Bone Diseases and Osteoporosis Section, Humanitas Clinical and Research Center, IRCSS, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Betella N; Endocrinology, Diabetology and Andrology Unit, Bone Diseases and Osteoporosis Section, Humanitas Clinical and Research Center, IRCSS, Rozzano (MI), Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Lania AG; Endocrinology, Diabetology and Andrology Unit, Bone Diseases and Osteoporosis Section, Humanitas Clinical and Research Center, IRCSS, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Pokaż więcej
Źródło :: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Oct 01; Vol. 105 (10).
Typ publikacji :: Letter; Comment
MeSH Terms :: Bone Density Conservation Agents*
Osteoporosis, Postmenopausal*
Bone Density ; Denosumab ; Electronic Health Records ; Female ; Humans
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT.
Autorzy :: Hettchen M; Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
von Stengel S; Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Kohl M; Department of Medical and Life Sciences, University of Furtwangen, Schwenningen, Germany.
Murphy MH; Doctoral College, Ulster University, Newtownabbey, Antrim, Northern Ireland, UK.
Shojaa M; Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Ghasemikaram M; Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Bragonzoni L; University of Bologna, Campus Rimini, Rimini, Italy.
Benvenuti F; University of Bologna, Campus Rimini, Rimini, Italy.
Ripamonti C; Center for Osteoporosis and Bone Metabolic Disease, Rizzoli Orthopaedic Institute, Bologna, Italy.
Benedetti MG; Physical Medicine and Rehabilitation Unit, IRCCS - Rizzoli Orthopaedic Institute, Bologna, Italy.
Julin M; Laurea University of Applied Sciences, Espoo, Finland.
Risto T; Laurea University of Applied Sciences, Espoo, Finland.
Kemmler W; Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.; Pokaż więcej
Źródło :: Clinical interventions in aging [Clin Interv Aging] 2021 Jan 11; Vol. 16, pp. 83-96. Date of Electronic Publication: 2021 Jan 11 (Print Publication: 2021).
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Bone Diseases, Metabolic*/diagnosis
Bone Diseases, Metabolic*/therapy
Osteoporosis, Postmenopausal*/diagnosis
Osteoporosis, Postmenopausal*/therapy
Postmenopause*
Bone Density Conservation Agents/*therapeutic use
High-Intensity Interval Training/*methods
Metabolic Syndrome/*prevention & control
Bone Density ; COVID-19/epidemiology ; Female ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Middle Aged ; Outcome Assessment, Health Care ; Risk Factors ; Risk Reduction Behavior
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose.
Autorzy :: Sha NN; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai, China.
Zhang JL; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Poon CC; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, China.
Li WX; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li Y; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang YF; National TCM Clinical Research Base of Hypertension, the affiliated Hospital of Shandong University of TCM, Jinan, China.
Shi W; National TCM Clinical Research Base of Hypertension, the affiliated Hospital of Shandong University of TCM, Jinan, China.
Lin FH; Department of Orthopaedic, Shenzhen Pingle Orthopaedic Hospital, Shenzhen, China.
Lin WP; Department of Orthopaedic, Shenzhen Pingle Orthopaedic Hospital, Shenzhen, China.
Wang YJ; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai, China.
Zhang Y; Spine Disease Research Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai, China.; Pokaż więcej
Źródło :: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2021 Jan 01; Vol. 320 (1), pp. E55-E70. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Angiotensin I/*pharmacology
Angiotensin II/*pharmacology
Bone Density Conservation Agents/*pharmacology
Bone and Bones/*drug effects
Glucose/*adverse effects
Peptide Fragments/*pharmacology
3T3 Cells ; Angiotensin II Type 1 Receptor Blockers/pharmacology ; Animals ; Bone Density/drug effects ; Bone Development/drug effects ; Male ; Mice ; Osteoblasts/drug effects ; Osteoclasts/drug effects ; Osteoporosis/prevention & control ; Phosphorylation/drug effects ; RAW 264.7 Cells ; Rats ; Rats, Inbred SHR
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study.
Autorzy :: Chen CL; Division of Nephrology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Chen NC; Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Wu FZ; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Radiology, Kaohsiung Veterans General Hospital, 386 Ta-Chung 1st Rd., Kaohsiung, 813, Taiwan.
Wu MT; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan. .; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. .; Department of Radiology, Kaohsiung Veterans General Hospital, 386 Ta-Chung 1st Rd., Kaohsiung, 813, Taiwan. .; Pokaż więcej
Źródło :: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2020 Aug; Vol. 31 (8), pp. 1507-1516. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Calcinosis*/prevention & control
Cardiovascular Diseases*/prevention & control
Denosumab*/therapeutic use
Hyperparathyroidism, Secondary*/complications
Hyperparathyroidism, Secondary*/drug therapy
Kidney Failure, Chronic*/complications
Kidney Failure, Chronic*/therapy
Bone Density ; Humans ; Pilot Projects ; Renal Dialysis/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Real-world effectiveness of osteoporosis treatment in the oldest old.
Autorzy :: Ström O; Karolinska Institutet, Stockholm, Sweden. .; Quantify Research, Stockholm, Sweden. .
Lauppe R; Quantify Research, Stockholm, Sweden.
Ljunggren Ö; Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
Spångéus A; Linköping University, Linköping University Hospital, Linköping, Sweden.
Ortsäter G; Quantify Research, Stockholm, Sweden.
O'Kelly J; Amgen Ltd, Uxbridge, UK.
Åkesson K; Lund University, Skåne University Hospital, Malmö, Sweden.; Pokaż więcej
Źródło :: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2020 Aug; Vol. 31 (8), pp. 1525-1533. Date of Electronic Publication: 2020 Mar 30.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Fractures, Bone*/epidemiology
Osteoporosis*/drug therapy
Aged, 80 and over ; Bone Density ; Female ; Humans ; Sweden/epidemiology ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Anabolic Therapy and Optimal Treatment Sequences for Patients With Osteoporosis at High Risk for Fracture.
Autorzy :: Cosman F; From the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.. Electronic address: .; Pokaż więcej
Źródło :: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2020 Jul; Vol. 26 (7), pp. 777-786. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Bone Density Conservation Agents*/therapeutic use
Fractures, Bone*/epidemiology
Fractures, Bone*/etiology
Fractures, Bone*/prevention & control
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*
Bone Density ; Female ; Humans ; Teriparatide/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
Autorzy :: Matsumoto T; Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, 770-8530, Japan. .
Yamamoto K; Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Takeuchi T; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
Tanaka S; Department of Orthopaedic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Nakano T; Tamana Central Hospital, Tamana, Kumamoto, Japan.
Ito M; The Open University of Japan, Nagasaki, Nagasaki, Japan.
Tomomitsu T; Department of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Hirakawa A; Department of Biostatistics and Bioinformatics, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Soen S; Department of Orthopaedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Nara, Japan.; Pokaż więcej
Źródło :: Journal of bone and mineral metabolism [J Bone Miner Metab] 2020 Jul; Vol. 38 (4), pp. 522-532. Date of Electronic Publication: 2020 Mar 05.
Typ publikacji :: Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :: Bone Density*/drug effects
Glucocorticoids/*adverse effects
Hydroxycholecalciferols/*therapeutic use
Osteoporosis/*drug therapy
Osteoporosis/*physiopathology
Vitamin D/*analogs & derivatives
Biomarkers/metabolism ; Bone Density Conservation Agents/therapeutic use ; Bone Remodeling/drug effects ; Female ; Femur Neck/drug effects ; Femur Neck/physiopathology ; Hip/physiopathology ; Humans ; Hydroxycholecalciferols/adverse effects ; Hydroxycholecalciferols/pharmacology ; Kaplan-Meier Estimate ; Lumbar Vertebrae/drug effects ; Lumbar Vertebrae/physiopathology ; Male ; Middle Aged ; Spinal Fractures/epidemiology ; Vitamin D/adverse effects ; Vitamin D/pharmacology ; Vitamin D/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.
Autorzy :: Liu Z; Department of Spinal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Zhang M; Department of Neonatology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Shen Z; Department of Spinal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Ke J; Department of Spinal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Zhang D; Department of Spinal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Yin F; Department of Spinal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Dec 16; Vol. 15 (12), pp. e0243851. Date of Electronic Publication: 2020 Dec 16 (Print Publication: 2020).
Typ publikacji :: Journal Article; Meta-Analysis
MeSH Terms :: Randomized Controlled Trials as Topic*
Bone Density Conservation Agents/*adverse effects
Bone Density Conservation Agents/*therapeutic use
Glucocorticoids/*adverse effects
Osteoporosis/*chemically induced
Osteoporosis/*drug therapy
Adult ; Bone Density/drug effects ; Bone Density Conservation Agents/pharmacology ; Female ; Hip/pathology ; Humans ; Incidence ; Male ; Middle Aged ; Osteoporosis/physiopathology ; Spinal Fractures/epidemiology ; Spinal Fractures/physiopathology ; Treatment Outcome
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Romosozumab: A Review in Postmenopausal Osteoporosis.
Autorzy :: Paik J; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .
Scott LJ; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.; Pokaż więcej
Źródło :: Drugs & aging [Drugs Aging] 2020 Nov; Vol. 37 (11), pp. 845-855.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antibodies, Monoclonal/*therapeutic use
Bone Density/*drug effects
Osteoporosis, Postmenopausal/*drug therapy
Alendronate/administration & dosage ; Alendronate/therapeutic use ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacokinetics ; Bone Density Conservation Agents/administration & dosage ; Bone Density Conservation Agents/therapeutic use ; Clinical Trials, Phase III as Topic ; Female ; Fractures, Bone/epidemiology ; Fractures, Bone/prevention & control ; Humans ; Osteogenesis/drug effects ; Teriparatide/administration & dosage ; Teriparatide/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Bioassay-guided isolation and evaluation of anti-osteoporotic polysaccharides from Morinda officinalis.
Autorzy :: Zhang D; Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518104, China.
Zhang S; Center for Clinical Precision Medication, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: .
Jiang K; School of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: .
Li T; Center for Clinical Precision Medication, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: .
Yan C; Center for Clinical Precision Medication, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510006, China; School of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: .; Pokaż więcej
Źródło :: Journal of ethnopharmacology [J Ethnopharmacol] 2020 Oct 28; Vol. 261, pp. 113113. Date of Electronic Publication: 2020 Jul 12.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Biological Assay*
Morinda*/chemistry
Bone Density Conservation Agents/*pharmacology
Bone Remodeling/*drug effects
Femur/*drug effects
Lumbar Vertebrae/*drug effects
Osteoblasts/*drug effects
Osteoporosis, Postmenopausal/*prevention & control
Polysaccharides/*pharmacology
3T3 Cells ; Animals ; Bone Density/drug effects ; Bone Density Conservation Agents/isolation & purification ; Chemical Fractionation ; Disease Models, Animal ; Female ; Femur/pathology ; Femur/physiopathology ; Humans ; Lumbar Vertebrae/pathology ; Lumbar Vertebrae/physiopathology ; Mice ; Osteoblasts/metabolism ; Osteoblasts/pathology ; Osteogenesis/drug effects ; Osteoporosis, Postmenopausal/pathology ; Osteoporosis, Postmenopausal/physiopathology ; Ovariectomy ; Polysaccharides/isolation & purification ; Rats, Sprague-Dawley
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bone Density"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język